Advertisement Nanotechnology for Active Pharmaceutical Ingredients - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

Nanotechnology for Active Pharmaceutical Ingredients

Our patented MJR-technology can be applied to different types of active pharmaceutical ingredients (APIs) for the production of nanoparticles and drug delivery systems.

APIs for nanoparticles and drug delivery systems

The MJR-Technology can be applied to different types of active pharmaceutical ingredients (APIs):

  • Small molecules
  • Peptides
  • Hormones
  • Vaccines

leon-nanodrugs can produce the following nanoparticles and drug delivery systems under GMP conditions:

  • Naked nanoparticles
  • Polymer coated API nanoparticles
  • Multilayer nanoparticles
  • Functionalised multilayer nanoparticles
  • Polymer nanoparticles functionalised with API
  • Polymer nanoparticles with API molecules on the surface and in the particle
  • Nanoemulsions
  • Coated nanoemulsions

nanoparticles-drugs

Uses of nanoparticles

leon-nanodrugs’ nanoparticle formulations can be offered in various application forms, depending on the specific API, the therapeutic indication and specific therapeutical demands. We can provide immediate release formulations as well as sustained release formulations of different application forms, such as:

  • Oral formulations (tablets, capsules, liquids, medical chewing gums)
  • Parenteral formulations
  • Semi-liquid formulations
  • Trans-dermal systems (TDS)
  • Complex drug delivery systems
Quick Contact Nanotechnology for Active Pharmaceutical Ingredients